Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy

J Natl Cancer Inst. 1993 Jan 6;85(1):60-2. doi: 10.1093/jnci/85.1.60.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bleomycin / administration & dosage
  • Carboplatin / administration & dosage
  • Carboplatin / therapeutic use
  • Cisplatin / administration & dosage
  • Cisplatin / therapeutic use
  • Cyclophosphamide / administration & dosage
  • Dactinomycin / administration & dosage
  • Etoposide / administration & dosage
  • Etoposide / adverse effects*
  • Humans
  • Leukemia, Myeloid, Acute / chemically induced*
  • Leukemia, Myeloid, Acute / genetics
  • Male
  • Mediastinal Neoplasms / drug therapy
  • Neoplasms, Germ Cell and Embryonal / drug therapy*
  • Neoplasms, Second Primary / chemically induced*
  • Remission Induction
  • Salvage Therapy
  • Testicular Neoplasms / drug therapy
  • Vinblastine / administration & dosage

Substances

  • Bleomycin
  • Dactinomycin
  • Vinblastine
  • Etoposide
  • Cyclophosphamide
  • Carboplatin
  • Cisplatin

Supplementary concepts

  • JEB protocol
  • VAB-6 regimen
  • VP-P protocol